Windlas Biotech Limited

NSE WINDLAS.NS

Windlas Biotech Limited EBITDA Margin for the year ending March 31, 2024: 14.52%

Windlas Biotech Limited EBITDA Margin is 14.52% for the year ending March 31, 2024, a 6.17% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Windlas Biotech Limited EBITDA Margin for the year ending March 31, 2023 was 13.68%, a 7.21% change year over year.
  • Windlas Biotech Limited EBITDA Margin for the year ending March 31, 2022 was 12.76%, a 50.55% change year over year.
  • Windlas Biotech Limited EBITDA Margin for the year ending March 31, 2021 was 8.48%, a -36.66% change year over year.
  • Windlas Biotech Limited EBITDA Margin for the year ending March 31, 2020 was 13.38%, a -55.75% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
SV Wall Street
NSE: WINDLAS.NS

Windlas Biotech Limited

CEO Ms. Komal Gupta
IPO Date Aug. 16, 2021
Location India
Headquarters 705-706, Vatika Professional Point
Employees 1,154
Sector Health Care
Industries
Description

Windlas Biotech Limited operates as a contract development and manufacturing organization (CDMO). Its CDMO services include product discovery, product development, licensing, and commercial manufacturing generic products, including generic products. The company provides its CMDO products and services across a range of pharmaceutical and nutraceutical conventional, and novel products for customers who market such products under their own brand names to the end users. It also offers manufactures various domestic trade generics and over-the-counter brand product portfolio to cater to nutritional, ayurvedic, wellness, and personal care markets. The company's domestic trade generics and OTC brands products are distributed through the offline channel, such as distributors, stockists, retail pharmacies, and institutional tenders, as well as the online channel, such as various e-commerce platforms. It exports its products primarily to Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. The company was incorporated in 2001 and is based in Gurugram, India.

Similar companies

DEVYANI.NS

Devyani International Limited

USD 1.93

3.12%

CHEMPLASTS.NS

Chemplast Sanmar Limited

USD 5.37

3.06%

KRSNAA.NS

Krsnaa Diagnostics Limited

USD 9.51

3.35%

NUVOCO.NS

Nuvoco Vistas Corporation Limited

USD 4.01

4.21%

CARTRADE.NS

CarTrade Tech Limited

USD 17.79

12.61%

StockViz Staff

January 30, 2025

Any question? Send us an email